Finance & valuation

Latest content

What college football can teach SPAC sponsors

SPACs can learn much from Coach Saban’s so-called ‘seven-second process’, reshaping it into a unique method to keep investors excited about target businesses and their intangible assets during the dreaded transfer portal period.

15 February 2023

UK R&D innovator to see 1,452% revenue boost from $150M Samsung settlement

Nanoco Group pockets $90 million after attorneys and a litigation finance firm are paid

03 February 2023

Former USPTO Director Andrei Iancu calls for robust IP regime to keep pace with China

America risks losing ground in the next tech revolution he warns in an interview with Burford Capital Managing Director Katharine Wolanyk

17 January 2023

Patent litigation finance booming while insurance market evolving, providers say

Industry practitioners remain optimistic against an unstable financial backdrop

04 January 2023

‘The devil is in the detail' – the Qualcomm take on patent licensing

QTL General Manager John Han speaks to IAM about essentiality checks and valuation during negotiations as well as future pool participation

22 December 2022

Second buyer emerges in bid for BlackBerry’s 38,000 patents

New contender is a large firm that does not need external financing but original buyer Catapult IP Innovations is now in final negotiations with new financial partners

21 December 2022

Storage Wars: the price of overlooking hidden intangible assets

Companies are failing to conduct proper due diligence assessments that consider intangible assets, which is proving detrimental to their organisation’s true value.

30 November 2022

Five key patent transactions takeaways

An over-arching theme during an IAM event was the key importance of relationships, trust and empathy between parties when deals are getting done

11 November 2022

WiLAN revenues plummet in Q3 on prior year but Micron deal excluded

Strategic review of the licensing business nears a year in motion with no news on potential divestment announced

10 November 2022

Drug royalty agreements can help Big Pharma overcome patent cliffs, says top dealmaker

Behzad Khosrowshahi, CEO of DRI Healthcare Trust, looks at recent deals the firm has done, explains what makes a transaction attractive and how to get one over the line

04 November 2022

• <
• 1
• 2
• ...
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• ...
• >